Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cosmetics Legislation Misses 2016 Window, But Is Real Industry Opportunity Now?

Jan 09 2017

• By Ryan Nelson

Related Content

FDA: Ingredient Safety Decisions Under PCPSA Could Differ From CIR

Oct 14 2016

FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill

Nov 04 2016

Industry Makes Pitch For National Uniformity At Senate HELP Hearing

Sep 27 2016

House Cosmetic Bills Conflict On Preemption, Cast PCPSA As Compromise

Sep 20 2016

Pallone/Lance Cosmetics Proposal Leaves Preemption Blanks To Be Filled

Sep 16 2016

Additional Topics

United States Legislation Regulation Cosmetics Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.